ACER
$2.02
Acer Therapeutics
$.01
.50%
ACER
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.23)
Revenue:  N/A
Friday
Feb 18
5:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ACER reports earnings?
Beat
Meet
Miss

Where is ACER's stock price going from here?
Up
Flat
Down
Stock chart of ACER
Analysts
Summary of analysts' recommendations for ACER
Score
Grade
Pivots
Resistance
$2.48
$2.26
$2.13

$1.91

Support
$1.78
$1.56
$1.43
Tweet
Growth
Description
Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics, Inc., is based in Cambridge, United States.